Virica
Ottawa · 2 known investors
Virica develops small-molecule cell enhancers called Viral Sensitizers (VSE) that temporarily reduce host cell defenses to increase viral vector yields, quality, and scalability during production. Its products serve cell and gene therapy and vaccine manufacturers, aiming to lower manufacturing costs and improve patient access.
Investors · 2
In the news
Frequently asked questions
- What does Virica do?
- Virica develops small-molecule cell enhancers called Viral Sensitizers (VSE) that temporarily reduce host cell defenses to increase viral vector yields, quality, and scalability during production. Its products serve cell and gene therapy and vaccine manufacturers, aiming to lower manufacturing costs and improve patient access.
- Who are Virica's investors?
- Virica's investors include Dynamk Capital, Avant Bio.
- Where is Virica headquartered?
- Virica is headquartered in Ottawa.